Drugmaker Astellas Has Claims For DOJ Settlement Coverage
By Elizabeth Daley · November 29, 2022, 6:38 PM EST
Pharmaceutical company Astellas' settlement with the U.S. Department of Justice for more than $102 million over its alleged Medicare fraud scheme involving medication for castration-resistant prostate cancer may be covered by...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login